Table 2.

Correlations and statistical significance among female patients

	Age at treatment	Age at treatment (ABVD group)	Age at treatment (BEACOPP group)	ABVD vs. BEACOPP	ABVD vs. eBEACOPP	bBEACOPP vs. eBEACOPP
Number of children before treatment	p < 0.001 a	p = 0.002 a	p < 0.001 a	p = 0.297b	p = 0.027 b	p = 0.168b
Therapy-induced amenorrhea	p = 0.016 c	p = 0.118c	p = 0.029 c	p = 0.002 d	p < 0.001 d	p = 0.712d
Restored menses after treatment	p = 0.062c	p = 0.348c	p = 0.010 c	p = 0.012 d	p = 0.032 d	p = 1.000d
Secondary amenorrhea	p = 0.062c	p = 0.348c	p = 0.010 c	p = 0.003 d	p = 0.494d	p = 1.000d
Pregnancies after therapy	p = 0.014 c	p = 0.095c	p = 0.051c	p = 0.630d	p = 0.174d	p = 0.425d
Children after therapy (yes/no)	p = 0.010 c	p = 0.079c	p = 0.040 c	p = 0.070d	p = 0.155d	p = 0.225d
Number of children after therapy	p = 0.032 a	p = 0.191a	p = 0.124a	p = 0.297b	p = 0.122b	p = 0.205b
Menopausal symptoms	p < 0.001 c	p = 0.013 c	p = 0.015 c	p = 0.095d	p = 0.984d	p = 0.454d
Severity of symptoms	p = 0.665e	p = 0.983e	p = 0.511e	p = 0.657b	p = 0.766b	p = 0.836b

Italic values indicate statistical significance

^aANOVA test

^bMann-Whitney test

^c t test

^dChi-square

^ePearson’s correlation